The Complicated Effects of Extracellular Vesicles and Their Cargos on Embryo Implantation

Jiang NX, Nan-Xing Jiang, Li XL, Xue-Lian Li, Xue‐Lian Li
Frontiers in endocrinology · 2021 · vol. 12 , pp. 681266 · doi:10.3389/fendo.2021.681266 · PMID:34149619 · PMC8213030 · W3171330041
Review OA: gold CC0 ⤵ 2 in-corpus citations
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-11 ⓘ

This review summarizes the diverse effects and potential mechanisms of extracellular vesicles and their cargos on embryo implantation, highlighting their relevance to reproductive diseases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-11 · read from full text ⓘ

This paper is a systematic review (PubMed/Medline/Ovid/Embase/Web of Science, last searched 25 April 2021) of how extracellular vesicles and their heterogeneous cargos affect embryo implantation, including evidence from both animal and human studies. Across implantation steps—endometrial receptivity, decidualization, and trophoblast invasion—the review reports that EVs from maternal tissues, embryos, seminal fluid, and the oviduct can alter adhesion, invasion, immune/inflammatory signaling, transcript expression, and trophoblast/outgrowth behaviors, with several studies noting cycle-dependent or embryo-competence–dependent EV cargo/size changes; a key caveat emphasized is the lack of consensus on EV nomenclature and inclusion/exclusion criteria (e.g., apoptotic bodies were excluded). The review also discusses limitations typical of qualitative synthesis and highlights examples such as endometrial exosomes affecting focal adhesion kinase signaling and embryo-derived EVs influencing endometrial epithelial gene expression. Relevance to endometriosis: the review’s search strategy explicitly included endometriosis and recurrent implantation failure among conditions linked to altered implantation, while the paper summarizes EV-related effects in reproductive diseases including those involving pelvic inflammatory pathology such as endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

As a rate-limiting step in pregnancy, embryo implantation is highly dependent on intercellular communication. Extracellular vesicles (EVs) are newly identified to be important in the course of intercellular communication. EVs have been isolated from a wide variety of biofluids and tissues, including plasma, liver, uterine, semen, embryo, etc. The present and future use of EVs not only as biomarkers, but also as targeting drug delivery system, is promisingly pave the way for advanced comprehension of implantation failure in reproductive diseases. However, as the precise mechanisms of EVs in embryo implantation has not been elucidated yet. Herein, we summarize the current knowledge on the diverse effects of EVs from various sources and their cargos such as microRNA, long non-coding RNA, protein, etc. on embryo implantation, and the potential mechanisms of EVs in reproductive diseases such as recurrent implantation failure, polycystic ovary syndrome and endometriosis. It is essential to note that many of the biologically plausible functions of EVs in embryo implantation discussed in present literatures still need further research in vivo.
Full text 34,181 characters · extracted from pmc-nxml · 10 sections · click to expand

Evs

It is widely accepted that women with a history of reproductive diseases such as recurrent implantation failure (RIF), polycystic ovary syndrome (PCOS), and endometriosis, are associated with future impaired embryo implantation ( 101 – 105 ). EVs-based intercellular communication plays an important role in female reproductive microenvironments and is involved in the pathogenesis of these disorders ( 59 , 89 , 106 – 109 ). The regulatory disorders caused by abnormal EVs may provide a new viewpoint of implantation failure in women with reproductive diseases (summarized in Table 3 ). There are 9 EVs-related references in Section 7 (3 for endometriosis; 4 for PCOS; 2 for RIF). EVs in reproductive diseases and their potential roles in embryo implantation disorders. Endometriosis is defined by the presence of viable endometrial tissue outside the uterine cavity ( 103 ). A number of implantation markers such as αvβ3 integrin, LIF, homeobox A10 (HOXA10) and HOXA11 are aberrantly expressed in patients with endometriosis and may contribute to infertility in some women with endometriosis ( 103 ). Endometrial defects and defective endometrial-embryo cross-talk are both proposed mechanisms of implantation failure in endometriosis ( 103 , 111 ). In recent years, the role of EVs in the process of implantation failure in endometriosis women is attracting increasing attention, and changes in the expression of certain proteins, lncRNAs and mRNAs may affect endometrial receptivity in rats with endometriosis during WOI, probably resulting in implantation failure of the embryo ( 89 , 90 , 108 , 110 ). EVs, including exosomes obtained from tissues (including endometrium, eutopic and ectopic endometriotic lesions, peritoneal fluid) and plasma samples of endometriosis women have unique miRNA-lncRNA characteristics ( 89 ). Forty-nine differentially expressed miRNAs are identified in eutopic endometrial stromal cells exosomes compared with that of normal endometrial stromal cells exosomes, and 12 miRNAs are predicted to target HOXA10, which is also a hopeful predictor of endometrial receptivity ( 112 , 113 ), and/or the LIF 3’ untranslated region ( 110 ). In addition, higher levels of angiogenic and inflammatory cytokines are present in the human umbilical vein endothelial cells cocultured with the endometriotic epithelial exosomes ( 89 , 108 ). The proinflammatory microenvironment stimulated by eutopic endometriotic lesions-derived EVs may also responsible for the disorders of embryo implantation in endometriosis ( 89 , 108 ). PCOS, one of the most common endocrine disorders in women, affects 8-13% of women of reproductive age ( 114 ). Nowadays, sufficient evidences have proved that hormonal disturbances as well as metabolic changes in PCOS women can both affect endometrial receptivity and embryo implantation ( 101 , 102 ). At gene level, there is a differential gene expression in endometrium of PCOS detected by microarray evaluation ( 115 , 116 ). It is noteworthy that most of these genes are involved in steroid hormone synthesis, inflammation and oxidative stress, which are indispensable for the establishment of endometrial receptivity ( 116 ). The proteome pattern of endometrium during WOI in PCOS women is significantly different with that of normal female ( 117 , 118 ). These differences in transcription, post-transcriptional modification and translation are often related to metabolism, cell cycle, DNA repair, apoptosis and signal transduction ( 116 ), and may consequently cause impaired endometrial receptivity in PCOS women. But the specific mechanisms are still unknown. Researches on EVs may provide new insights into the further understanding of implantation failure in PCOS. RNA sequencing microarray and proteomic analysis have shown differentially expressed small RNAs, circRNAs, and 86 proteins in follicular fluid exosomes of PCOS women ( 106 , 107 , 119 , 120 ). The alterations of the proteomic profile of PCOS women are related to the inflammation, reactive oxygen species metabolic process, cell migration and proliferation ( 106 ), which are closely related to embryo implantation. S100‐A9 protein in exosomes derived from follicular fluid promotes inflammation and causes disorders of ovarian steroidogenesis via activation of NF‐κB pathway ( 106 ). The down-regulated exosomal circLDLR in follicle fluid of PCOS women is proposed to involve in abnormal estrogen secretion as well ( 107 ). Chronic inflammation is an acknowledged cause of endometrial physiological dysfunction ( 121 , 122 ). Excessive inflammation results in the adverse pregnancy outcomes in PCOS and endometriosis. The articles above ( 106 , 107 ) specialize in local inflammation and steroidogenesis of the ovary, and the disorders of ovarian steroidogenesis and abnormal inflammatory state caused by follicle fluid exosomal cargos may also be the potential mechanisms of the disorders of embryo implantation in PCOS. RIF refers to the repeated transfer of morphologically good embryos to a normal uterus without achieving successful implantation and a clinical pregnancy ( 123 ). Traditionally, the failure to achieve a clinical pregnancy after transfer of at least four good-quality embryos in a minimum of three fresh or frozen cycles in a woman under the age of 40 years is defined as RIF ( 105 ). The etiologies and pathogenesis of RIF is unknown, and clarifying the mechanisms of EVs in RIF may provide benefits to the treatments of embryo implantation disorders. Altered miRNA profiles in RIF-EVs might be involved in the pathogenesis of RIF. The up-regulated miR-1246 and miR-1290 in the RIF-EVs may indicate the inadequate endometrial receptivity of RIF women ( 124 ). In vitro experimental studies have demonstrated that endometrial EVs from RIF women attenuate embryonic development and implantation capacity by inhibiting blastocyst formation, decreasing the total cell number of embryos as well as inhibiting the proliferation, migration, and invasion of trophoblast cells ( 59 , 109 ).

Rna

MiRNAs are a class of small non-coding RNAs that regulate gene expression either negatively by inhibition of translational repression or positively through the targeting of gene promoters ( 60 ). EV is one of the main carriers of miRNA in vivo ( 60 , 61 ). The bilayer phospholipid membrane structure of EVs protects miRNAs from degradation and contributes to their stability ( 26 ). Evidences suggested that heterogeneous nuclear ribonucleoprotein C1 (hnRNPC1) may be involved in the internalization of endometrial miR-30d into exosomes to prepare for its subsequent incorporation into trophectoderm cells ( 62 , 63 ). However, it is still unknown whether this protein is generally involved in miRNAs integration in EVs. Emerging evidences suggest the considerable role of EVs-derived miRNAs in embryo implantation events ( 27 , 60 ). Among them, members of lethal-7, miR-30, miR-21 families are especially remarkable ( 64 ). Other miRNAs, such as miRNA-17-92 cluster, miR-29a, etc., have been proved to be closely related to embryo implantation process despite the temporary lack of EVs-related evidences ( 64 , 65 ). There are 18 EVs-related references in this section. The let-7 family, which has 12 members up to now, is important for cell development and proliferation inhibition ( 66 ). The diversity of let-7 is particularly noticeable for the establishment of endometrial receptivity and embryonic development ( 66 – 69 ). During the whole event of embryo implantation, the expression level of let-7 family is dynamic ( 66 , 67 ). In the preparation stage of embryo implantation, up-regulated let-7a/g in endometrial epithelial cells enhance endometrial receptivity by inhibiting the classical Wnt signaling pathway ( 68 ). It is well known that the acquisition of endometrial receptivity mainly depends on the precise control of estrogen and progesterone ( 70 , 71 ). The level of miR-let-7a is regulated by estrogen and progesterone ( 68 ), which suggests that let-7 may be involved in the regulation of steroid hormones on embryo implantation ( 68 ). Interestingly, the expression level of let-7 family members (including let-7a/g) was significantly decreased in the developed blastocysts during implantation ( 67 ), which is contrary to what is found in endometrial epithelial cells. A recent study has shown that placental exosome-derived bta-miR-499-5p is involved in the inhibition of NF-κB through the Lin28B/let-7 axis ( 72 ). As a member of the let-7 family, EVs-derived miR-98 regulates the maternal immune system of endometrium during the period of peri-implantation by regulating immune-related genes such as CTSC, IL6, CASP4 and IKBKE ( 69 ). The effect of let-7 on the regulation of immune response may be related to the apoptosis of endometrial cells and embryo implantation ( 69 , 72 ), but further experiments are needed. A recent study has expanded the understanding of the regulatory role of let-7 family on embryo. Let-7 is a major factor that induces diapause in embryos. Let-7-containing EVs from uterine fluid induce mouse embryonic diapause by inhibiting c-myc/mTORC1 and mTORC2 signaling pathways ( 73 , 74 ). Over-expression of EVs-derived let-7 potentially hamper trophoblast differentiation and the implantation capacity of embryo ( 73 , 74 ). As mentioned above, hnRNPC1 may be involved in the internalization of endometrial miR-30d into exosomes to prepare for its subsequent incorporation into trophectoderm cells ( 62 , 63 ). During WOI, up-regulated miR-30 family in human endometrial epithelium is secreted into uterine fluid as exosome-associated molecule ( 75 , 76 ). Hsa-miR-30d, secreted by human endometrium and taken up by the pre-implantation embryo, might modify its transcriptome, increase the adhesion rate via indirect overexpression of genes encoding for certain molecules involved in embryonic adhesion phenomenon, such as Itgb3, Itga7 and Cdh5 ( 75 ). The miR-21 family has anti-apoptotic effects on many cellular biological processes, including regulating anti-apoptotic ability of preimplantation embryos ( 77 ). In pregnant mice, increased EVs and miR-21 in uterine luminal fluid regulate the growth of fertilized eggs and embryo development via apoptosis-related gene (Bax, Bcl-2, etc.) ( 78 ). Sus scrofa (ssc)-miR-21-5p regulates endometrial epithelial cell proliferation, apoptosis and migration via programmed cell death 4 (PDCD4)/AKT pathway ( 79 ). Of note, the research progress of EVs-related miRNAs in embryo implantation is not limited to the above-mentioned families. During implantation, the expression of EVs-derived miRNAs, such as miR-34c-5p, miR-210 are significantly up-regulated in extracellular environment of uterine ( 80 ). Exosomal miR-100-5p not only promotes angiogenesis during implantation, but also activates both FAK and JNK to enhance the implant potency of trophoblasts ( 81 ). Moreover, despite the temporary lack of EVs-related evidences, numerous miRNAs have also been proved to play a regulatory role in embryo implantation ( 64 , 65 ). It’s worthy to study whether EVs participate in the interaction between these miRNAs and embryo implantation. The specific discussion is as follows. MiRNA-17-92 cluster is up-regulated at implantation site during WOI ( 64 ). Similarly, miR-29a is highly expressed in uterus to control implantation events ( 65 ), which may be achieved by inhibiting the apoptosis of eSC via targeting the pro-apoptotic factor genes Bak1, Bmf and the anti-apoptotic factor gene Bcl-w. As we all know, Cox-2-derived prostaglandins are critical to implantation, and a research have found that miR-101a and miR-199a regulate the implantation process by regulating Cox-2 post transcriptionally ( 82 ). MiR-31 targets immunoregulatory factors like FOXP3, CXCL12 and so on to achieve optimal endometrial receptivity through immunosuppression mechanisms ( 83 ). However, miRNAs are complex and precise regulatory factor, and some miRNAs play negative regulatory roles during the process of embryo implantation. Higher expression of miR-200 family members is found in the serum of infertility and abortion women compared with that of healthy women ( 84 ). In vitro experiments have demonstrated that miR-200c inhibits proliferation and receptive ability of uterine epithelial cells via miR-200c/FUT4/α-1,3-fucosylation (LeY)/CD44/Wnt/β-catenin signal pathway ( 84 ). In addition, miR-661, which is specifically secreted by implantation-incompetent blastocysts, negatively regulates the adhesion of trophoblasts onto epithelium via PVRL1 in vitro , and may be involved in the breakdown of intercellular contact and loss of epithelial cell polarity in endometrium ( 85 ). Higher expression of miR-181b is also found in degenerated bovine embryos compared with fine blastocysts ( 86 ). The above results (summarized in Table 2 ) strongly support the important role of miRNAs in embryo implantation, and the analysis of miRNAs describe a promising picture of the future in assisted reproduction. But the expression profiles of miRNAs are very variable in these studies mainly because of the complexity of miRNA signals, different species of experimental animals and individual heterogeneity ( 60 ). So, the emergence of new methodologies for miRNA extraction and quantification is urgently needed, and the role of EVs in embryo implantation needs to be discussed in categories. In the seventh section of this review, we will focus on the adverse effects of EVs on pathological embryo implantation. The reported miRNA cargos and their implication in embryo implantation. As the most heterogeneous class of non-protein-coding RNA, with lengths ranging from 200 to 100,000 nt, lncRNAs are involved in almost all biological processes ( 87 ). EVs may be involved in the process of lncRNAs avoiding the degradation of ubiquitous RNase in body fluids, so as to reach target cells and play a regulatory role ( 87 , 88 ). So far, there are few studies on EVs-derived lncRNAs in embryo implantation, but the research progress of EVs-derived lncRNAs in some endometrium-related diseases has brought clues for future research. EVs from endometriosis women are characterized by a unique miRNA-lncRNA signature ( 89 ), which may affect endometrial receptivity during WOI result in implantation failure ( 90 ). Decidualization and angiogenesis are typical changes in the endometrium during implantation, and antisense hypoxia-inducible factor (aHIF) is a well-known angiogenesis-related lncRNA ( 87 ). Endometriotic cyst stromal cells-derived exosomal aHIF induces angiogenesis by regulating angiogenesis-related genes in human umbilical vein endothelial cells ( 87 ). Some other specific lncRNAs are associated with endometrial physiopathology and embryo implantation ( 91 , 92 ). LIF is a kind of cytokine secreted by endometrial glands and plays an amazingly important role in embryo implantation during WOI ( 93 , 94 ). As a competing endogenous RNA for miR‐15b, lncRNA882 regulates LIF by sponging miR‐15b in endometrial epithelium cells of dairy goat ( 95 ). (There are 3 EVs-related references in this section.)

Intro

Implantation is a continuous dynamic process during which the blastocyst is implanted in the receptive endometrium in the mid-luteal phase. Embryo implantation is the starting point and a rate-limiting step of pregnancy. The success of embryo implantation mainly depends on two factors: zygote and corresponding establishment of endometrial receptivity. The essential processes of embryo implantation involve “location”, “adhesion” and “invasion”. Endometrial receptivity is present only for a very short time in the mid-secretory phase of each menstrual cycle, typically occurring in the 22th to 24th days of the cycle ( 1 ). This fleeting moment is called “windows of implantation (WOI)”. Contrary to the widespread belief, an article proposed that “embryo implantation” should more properly be regarded as the “war” between embryo and endometrium ( 2 ). The embryo uses a variety of coercive tactics to force its acceptance by endometrium. It’s not a cooperation or an accommodation, but an aggression and a conquest. This metaphor is not exaggerated because the natural conception rate of human is very low (only 30-40%) ( 3 ). Additionally, 75% of pregnancy losses are due to failed embryo implantation ( 4 ). Even with the help of assisted reproductive technology, the pregnancy rate is still low, the culprit remains implantation failure ( 5 , 6 ). Take polycystic ovary syndrome (PCOS) as an example, even we are able to obtain high-quality oocytes by controlled ovarian hyperstimulation and ideal blastocytes by in vitro fertilization, the rate of clinical pregnancy and live birth is still lower in women with PCOS comparing with that of women without PCOS, which is mainly due to the impaired endometrial receptivity ( 7 , 8 ). At present, embryo implantation has obviously become an unsolved hot issue in the field of reproductive medicine research, and the mechanisms of embryo implantation need further study. Embryo implantation only occurs when the development of embryo coordinate with the station of endometrium, which is highly dependent on intercellular communication ( 9 – 11 ). Intercellular communication in traditional sense relies on intimate physiology contact or soluble mediators in microenvironment such as hormones, growth factors, cytokines, chemokines and proteases ( 12 – 16 ). In recent years, a series of papers have revealed a bran-new communication mechanism that modulates embryo implantation, which is called intercellular communication mediated by extracellular vesicles (EVs) ( 13 , 17 , 18 ). The aim of this review is to summarize the current knowledge about the physiological roles of EVs produced by maternal tissues, embryo, semen as intercellular messengers in embryo implantation process. We have also reviewed how EVs affect embryo implantation in reproductive diseases.

Author

N-XJ wrote the manuscript. X-LL designed the topic and critically revised our work. All authors contributed to the article and approved the submitted version.

Methods

The present review includes three strategies: literature search, study selection, and results summary. A systematic review was performed using the PubMed, Medline (Ovid), Embase (Ovid), and Web of Science databases without additional limits ( Figure 1 ). We used the following query: (‘extracellular vesicles’ or ‘exosomes’ or ‘microparticles’ or ‘microvesicles’) and (‘embryo implantation’ or ‘embryo development’ or ‘endometrium’ or ‘polycystic ovary syndrome’ or ‘recurrent implantation failure’ or ‘endometriosis’). The last search was run on 25 April 2021. Both animal and human studies were considered suitable for this review. Research studies on EVs (“apoptotic bodies” and “apoptotic vesicles” are not included) or their regulation in embryo implantation, discussing either the endometrial receptivity, embryo, or both, were eligible for inclusion. Schematic of study selection. We identified 12121 articles after a primary search by the databases ( Figure 1 ), immediately excluded 3577 records because they were duplicated. Then two Reviewers independently screened articles by title and abstract, any discrepancies were resolved by consensus. 8338 records were excluded (including irrelevant topics, reviews, comments, replies or letters to the Editor). The remaining 206 articles were collected as full-texts. Finally, after full-text screening, 65 articles were used for qualitative analysis.

Protein

Proteomic profiling of endometrium has revealed that endometrial exosomes contain a number of unique exosomal proteins not previously identified in exosomes from any other tissues ( 29 ). These endometrium-derived exosomal proteins are primarily regulated by estrogen and progesterone during menstrual cycle ( 29 ), which is consistent with the establishment of endometrial receptivity ( 70 , 71 ). Importantly, proteomic changes in human trophectoderm function are demonstrated after endometrial EVs are internalized by human trophectoderm cells, which probably due to the transfer of EV protein cargos ( 26 ). Therefore, the expression differences of exosomal protein during the various stages of menstrual cycle may be closely related to embryo implantation. There are 5 EVs-related references in Section 6. Among the numerous exosomal proteins, matrix metalloproteinase (MMP), which may have potential roles in embryo-maternal crosstalk during implantation has attracted much attention ( 22 , 29 ). MMPs are widely expressed on maternal-fetal interface, responsible for extracellular matrix degradation and regulated by tissue inhibitors of MMPs (TIMPs) ( 96 , 97 ). Different expression of MMP2, MMP14, and TIMP2 is observed in endometrium during various phases of the estrous cycle ( 98 ). MMPs contribute to the spatial and temporal matrix remodeling in bovine endometrium and may be related to the invasive ability of trophoblast cell ( 96 ). Some MMPs are relevant to endometrial angiogenesis ( 99 ), which is essential for vascularized receptive endometrium. HLA-G is a key molecule in the process of embryo implantation, avoids the maternal immune rejection of the embryo by regulating the maternal-fetal immune response, and mediates communication with target cells in a variety of ways ( 100 ). The expression of HLA-G protein at the maternal-fetal interface is critical to the success of pregnancy, and HLA-G can be secreted with EVs ( 100 ). So far, researches on the role of EVs-derived proteins in embryo implantation process are still not in-depth. In vitro experiments have discovered that 254 and 126 proteins are uniquely enriched in endometrial-derived exosomes during the proliferation and receiving phases, respectively ( 29 ). Whether these numerous and diverse proteins can provide appropriate conditions for embryo needs further explosion.

Prospects

In conclusion, as one of the important communication mechanisms that modulate blastocyst and endometrial functions, EVs play an important role in promoting embryo implantation, which mainly owes to EVs’s unique ability in transferring heterogeneous cargos (summarized in Figure 2 ) ( 125 ). Abnormal EVs play a negative role in some pathological conditions. Summary of EVs and their implication in embryo implantation. Purple vesicles, endometrium-derived EV; Red vesicles, embryo-derived EVs; Green vesicles, EVs from other sources. EVs have shown great potential as molecular biomarkers in diagnosis, prognosis and also as possible therapeutic targets. Currently, endometrial dysfunction is the biggest obstacle to the treatment of embryo implantation disorders. EVs derived from serum and uterine fluid may be used, as a noninvasive and accurate marker of endometrial station, to identify women with implantation defects, demonstrate the optimal timing for embryo transfer, and replace the traditional endometrial biopsy ( 83 , 126 , 127 ). EVs-based preparation may be a promising approach to endometrial regeneration and improving pregnancy outcomes ( 128 ). But the precise mechanisms of EVs regulating embryo implantation have not been elucidated enough. The following points deserve attention and improvement particularly: 1. the data of EVs cargos are mainly derived from immortalized or long-term passaged cell lines. 2. there is still no golden standard of EVs separation, concentration and purification, and no acknowledged nomenclature of subclassing EVs with various biophysical properties. 3. the experimental data of effects of EVs in embryo implantation is largely based on in vitro trophoblast adhesion/invasion assays, but the corresponding in vivo evidence has not been rigorously established. 4. current understanding of EVs has been limited to protein and RNA cargos, but the role of EVs-derived DNA and lipid molecules in embryo implantation remains unknown. So further exploration of the effects of EVs and their cargos on embryo implantation is still needed.

Coi Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Extracellular

EVs are cell-derived membranous vesicles without specific targets. The cargos of EVs are heterogeneous, including nucleic acids (DNA, mRNA, microRNAs and long non-coding RNAs), proteins, lipids and so on. Almost all cells can produce and release EVs. Once released into extracellular space, EVs can produce local effects through autocrine and paracrine methods, Or be transported to distant organs or tissues through body fluids such as blood and lymph as important carriers for molecular exchange between different kinds of cells in short or long distance ( 19 ). However, there is still a lack of consensus on the nomenclature of EVs ( 19 ). We propose to distinguish three different types of EVs on the basis of biogenetic pathway and physical characteristics: 1. exosomes, 2. microparticles (MPs) (or microvesicles, MVs) and 3. apoptotic bodies ( 17 , 20 ). Exosomes are 40-120 nm size homogenous vesicles, which originated from multivesicular bodies ( 21 , 22 ) and enriched in major histocompatibility complex class I (MHC class I), MHC class II and tetraspanins such as CD6, CD9, CD63, CD81, as well as protein markers like Alix, TSG101 and chaperones ( 23 , 24 ).

Funding Information

This study was funded by Natural Science Foundation from Science and Technology Commission of Shanghai Municipality (grant No. 17ZR1403100 to X-LL).

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Embryo Implantation Endometrium Extracellular Vesicles Biomarkers Biomarkers Biomarkers Embryo Implantation Embryo Implantation Endometrium Endometrium Extracellular Vesicles Extracellular Vesicles Female Female Humans Humans Pregnancy Pregnancy Uterus Uterus

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (3)

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:31:21.846955+00:00
License: CC0 · commercial use OK